Designer drugs for discerning bugs.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Cryo-EM structure ofEmerging microbes & infections · 2022
   Article
2. Ribosomal Antibiotics: Contemporary Challenges.Antibiotics (Basel, Switzerland) · 2016
   Review
3. Natural Green coating inhibits adhesion of clinically important bacteria.Scientific reports · 2015
   Article
4. The chemistry of peptidyltransferase center-targeted antibiotics: enzymatic resistance and approaches to countering resistance.ACS chemical biology · 2012
   Review
5. Crystal structure of the synergistic antibiotic pair, lankamycin and lankacidin, in complex with the large ribosomal subunit.Proceedings of the National Academy of Sciences of the United States of America · 2011
   Article

Corrections and comments

• Comment on
  Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action.2010
• Comment on
  Revisiting the structures of several antibiotics bound to the bacterial ribosome.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as